```html

Nervous System Infections (e.g., Meningitis) – A Comprehensive Medical Guide

Overview

Nervous system infections encompass any infection that involves the brain, spinal cord, meninges (the protective membranes surrounding the brain and spinal cord), or the peripheral nerves. The most widely recognized example is meningitis, an inflammation of the meninges, but the term also includes encephalitis, brain abscesses, spinal epidural abscesses, and neuropathies caused by infectious agents.

These infections can be caused by bacteria, viruses, fungi, parasites, or even atypical organisms such as Mycobacterium tuberculosis. While anyone can be infected, certain groups—including infants, older adults, people with weakened immune systems, and those living in close quarters (e.g., college dorms, military barracks) – are at higher risk.

According to the World Health Organization (WHO), bacterial meningitis accounts for roughly 1.2 million cases worldwide each year, with a case‑fatality rate of 10–15% when treated promptly, but up to 50% in low‑resource settings. Viral meningitis is far more common (≈ 10–20 cases per 100,000 population annually in the U.S.) and usually less severe, yet it still requires careful evaluation.

Symptoms

Symptoms can develop abruptly (hours) in bacterial infections or gradually (days) with viral or fungal causes. Because early signs overlap with many other illnesses, it’s essential to recognize the full spectrum.

General Warning Signs (present in most nervous system infections)

• Fever – often >38°C (100.4°F); may be high‑grade in bacterial meningitis.
• Severe headache – described as “worst headache of my life.”
• Neck stiffness (nuchal rigidity) – difficulty bending the neck forward.
• Photophobia – sensitivity to light.
• Nausea or vomiting – sometimes vomiting is projectile.
• Altered mental status – confusion, lethargy, irritability, or seizures.

Additional Symptoms by Infection Type

Bacterial Meningitis

• Rapid onset (within 12‑24 hrs)
• Skin rash that does not blanch (purpuric or petechial), especially with Neisseria meningitidis
• Joint or muscle pain (myalgia)
• Rapid breathing or low blood pressure

Viral (Aseptic) Meningitis

• More gradual onset (2‑3 days)
• Often preceded by a respiratory or gastrointestinal illness
• Mild or absent rash
• Usually no focal neurological deficits

Encephalitis (Brain Inflammation)

• Focal neurological signs – weakness, speech difficulty, vision changes
• Behavioral changes, memory loss, or personality shifts
• Seizures are common

Fungal / Tuberculous Meningitis

• Insidious onset over weeks
• Weight loss, night sweats (TB)
• Chronic headache, low‑grade fever

Causes and Risk Factors

Common Causative Organisms

Category	Typical Pathogens	Notes
Bacterial	Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Listeria monocytogenes	Most severe; need immediate antibiotics.
Viral	Enteroviruses (coxsackie, echovirus), Herpes simplex virus (HSV‑1, HSV‑2), Arboviruses (West Nile, La Crosse), Varicella‑zoster	Often self‑limited; HSV may need antiviral therapy.
Fungal	Candida spp., Cryptococcus neoformans, Histoplasma capsulatum	Usually in immunocompromised hosts.
Mycobacterial	Mycobacterium tuberculosis	Chronic meningitis; higher mortality.
Parasitic	Naegleria fowleri (primary amoebic meningoencephalitis), Toxoplasma gondii	Rare, but fulminant.

Risk Factors

• Age: Infants <1 yr and adults >65 yr have higher susceptibility.
• Immune suppression: HIV/AIDS, chemotherapy, long‑term steroids, organ transplantation.
• Close living environments: Dormitories, military barracks, prisons.
• Recent upper respiratory infection: Viral prodrome can predispose to secondary bacterial infection.
• Smoking & alcohol misuse: Impairs mucosal immunity.
• Travel to endemic areas: Particularly for fungal (e.g., Cryptococcus in Sub‑Saharan Africa) or parasitic infections.
• Medical devices: Ventriculoperitoneal shunts, intraventricular catheters.

Diagnosis

Prompt diagnosis is critical because outcomes are closely tied to the speed of appropriate therapy.

Initial Clinical Assessment

• Detailed history (exposure, travel, immunizations, recent infections).
• Physical exam focusing on meningeal signs (Kernig, Brudzinski), neurological deficits, rash.

Laboratory & Imaging Tests

Lumbar Puncture (Spinal Tap)

Gold standard for meningitis. Cerebrospinal fluid (CSF) is evaluated for:

• Opening pressure (often elevated).
• Cell count – neutrophilic predominance in bacterial, lymphocytic in viral/fungal.
• Glucose – low in bacterial and TB meningitis.
• Protein – elevated in most infections.
• Gram stain, bacterial culture, PCR panels for viruses, fungal antigen testing.

Guidelines from the Infectious Diseases Society of America (IDSA) recommend obtaining CSF before antibiotics when feasible, but antibiotics should not be delayed if the patient is critically ill.

Blood Tests

• Complete blood count (CBC) – leukocytosis in bacterial infection.
• C‑reactive protein (CRP) and procalcitonin – higher in bacterial vs. viral etiology.
• Blood cultures – essential for bacteremia detection.

Neuroimaging

• CT scan (non‑contrast) – performed first if signs of raised intracranial pressure, seizures, focal deficits, or immunocompromise exist to rule out mass effect.
• MRI – more sensitive for encephalitis, abscesses, or complications such as hydrocephalus.

Rapid Diagnostic Platforms

Multiplex PCR panels (e.g., FilmArray Meningitis/Encephalitis) can identify >14 pathogens within an hour, improving early targeted therapy (JAMA, 2022).

Treatment Options

General Principles

• Start empiric antimicrobial therapy within 30 minutes of suspicion in adults and within 60 minutes in children (IDSA guidelines).
• Adjunctive therapy (e.g., dexamethasone) improves outcomes in bacterial meningitis caused by S. pneumoniae and H. influenzae.
• Supportive care – fluid management, antipyretics, seizure control, airway protection.

Bacterial Meningitis

1. Empiric Antibiotics (adjusted by age & risk):
   • Adults 18–50: ceftriaxone or cefotaxime + vancomycin.
   • Adults >50 or immunocompromised: Add ampicillin for Listeria.
   • Infants: Ampicillin + cefotaxime + vancomycin (per pediatric protocols).
2. Adjunctive Dexamethasone (0.15 mg/kg IV every 6 h for 2–4 days) – given before or with the first dose of antibiotics.
3. Duration – 7‑10 days for most bacteria; 10‑14 days for Streptococcus pneumoniae, 21 days for Listeria.

Viral (Aseptic) Meningitis

• Most cases are self‑limited; treatment focuses on hydration, analgesics, and monitoring.
• Herpes simplex virus (HSV) meningitis/encephalitis: Acyclovir 10‑15 mg/kg IV every 8 h for 14‑21 days.
• Enteroviral infections: No specific antivirals; supportive care only.

Fungal & Tuberculous Meningitis

• Candida: Fluconazole 400 mg PO/IV daily for 6 weeks.
• Cryptococcus: Induction with Amphotericin B 0.7 mg/kg + Flucytosine 100 mg/kg q6h for 2 weeks, followed by fluconazole consolidation for 8‑10 weeks.
• TB meningitis: RIPE regimen (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) for 2 months → Isoniazid + Rifampin + Pyridoxine for 7–10 months.

Adjunctive Measures

• Intracranial pressure (ICP) management – elevate head of bed, osmotic agents (mannitol) if needed.
• Seizure prophylaxis – levetiracetam in patients with proven encephalitis or recurrent seizures.
• Rehabilitation – physical, occupational, and speech therapy for residual deficits.

Living with Nervous System Infections (e.g., Meningitis)

Post‑Acute Care

• Follow‑up appointments with infectious disease and neurology within 1‑2 weeks of discharge.
• Repeat lumbar puncture may be required for TB or fungal meningitis to confirm sterilization.
• Vaccination updates – pneumococcal (PCV13/PPV23), meningococcal (MenACWY, MenB), Hib for those who have not received them.

Daily Management Strategies

1. Medication adherence – Use pill organizers or smartphone reminders for prolonged courses (e.g., TB therapy 9‑12 months).
2. Hydration & nutrition – Aim for 2–3 L fluid/day unless fluid‑restricted for cardiac/renal issues; incorporate protein‑rich foods to aid recovery.
3. Cognitive rest – Gradually return to reading, screen time, and driving as tolerated; avoid multitasking if concentration remains impaired.
4. Physical activity – Begin with short walks; progress under physiotherapist guidance to prevent deconditioning.
5. Monitor for late sequelae – Hearing loss, vision changes, chronic headaches, seizures, or mood disorders. Promptly report new symptoms.

Support Resources

• American Meningitis Association (meningitis.org) – peer support groups.
• CDC’s “Meningitis Fact Sheet” – up‑to‑date vaccine schedules.
• Local rehabilitation centers and neuro‑psychology services.

Prevention

• Vaccination:
  • 1‑month onward: Hib (Haemophilus influenzae type b).
  • 2, 4, 6 months + booster: PCV13 (pneumococcal conjugate).
  • Adolescence or high‑risk adults: MenACWY (serogroups A, C, W, Y) and MenB.
  • Annual flu vaccine – reduces secondary bacterial meningitis.
• Hand hygiene & respiratory etiquette: Wash hands with soap ≥20 seconds; cover coughs with tissue or elbow.
• Avoid sharing personal items (cups, utensils, lip balm) in communal settings.
• Prompt treatment of ear, sinus, or respiratory infections – decreases spread to meninges.
• Protective measures for at‑risk groups: Prophylactic antibiotics (rifampin, ciprofloxacin) for close contacts of a confirmed meningococcal case within 24 hrs (CDC).
• Safe travel practices: Use bottled water in endemic areas, avoid swimming in warm freshwater lakes where Naegleria thrives.

Complications

If treatment is delayed or ineffective, infections can lead to serious, sometimes permanent, sequelae.

• Neurological deficits: Permanent motor weakness, seizures, cranial nerve palsies.
• Hearing loss: Up to 10% of bacterial meningitis survivors; often sensorineural.
• Hydrocephalus: Obstructive or communicating; may need shunt placement.
• Stroke or cerebral infarction: Due to vasculitis or thrombosis.
• Cognitive and psychiatric effects: Memory impairment, attention deficits, depression, anxiety.
• Amicrotic (inflammatory) scarring: Leads to persistent headaches.
• Mortality: Bacterial meningitis mortality ranges 10–30% despite optimal care, higher in the very young, elderly, and immunocompromised.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, WHO, NIH National Institute of Neurological Disorders and Stroke, Cleveland Clinic, Infectious Diseases Society of America (IDSA) Guidelines, JAMA 2022; CDC Meningitis.

```